Scientists discover how antibiotic molecule found in bacteria stops breast cancer

August 22, 2011 in Cancer

(Medical Xpress) -- Scientists have discovered how a molecule that was first discovered in bacteria blocks a protein which causes breast cancer to develop and spread, reveals research published in Nature Chemistry today.

Scientists at Cancer Research UK’s Cambridge Research Institute, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and The University of Cambridge, have revealed at the molecular level how thiostrepton - a naturally-occurring cancer-protector molecule - ‘clamps’ a cancer-causing called FOXM1, preventing it from working.

FOXM1 is present in greater amounts in cells. It attaches to specific stretches of DNA - switching on genes regulating the growth and division of cells. It also causes tumours to spread and triggers the growth of blood vessels which supply tumours with nutrients for growth.

Blocking this protein may prevent the development of cancer at an early stage as well as block cancer growth and spread.

Designing drugs to stop proteins like FOXM1 is a huge challenge for scientists. But this new information will allow researchers to design small that mimic thiostrepton – but are even more effective at blocking the cancer-promoting effects of FOXM1.

Lead author, Professor Shankar Balasubramanian, based at Cancer Research UK’s Cambridge Research Institute, said: “Before this research we weren’t aware of any natural product which could directly target a protein that controls gene activity. Yet intriguingly a molecule in - which also has strong antibiotic effects - does this very well, switching off cancer-causing genes in breast cancer cells.

“This naturally-occurring molecule doesn’t have all the right properties to be used as a breast cancer treatment itself. But this exciting discovery paves the way for the design of more potent and selective drugs based on the structure of thiostrepton to block the FOXM1 protein.”

Around 48,000 women in the UK are diagnosed with breast cancer each year and around 12,100 UK women die from the disease.

Dr Lesley Walker, Cancer Research UK’s director of cancer information, said: “Survival rates for breast cancer have been improving for 30 years thanks to the development of more targeted treatments. But there is more to be done. One huge challenge is how to prevent breast cancer from spreading to other parts of the body – once a cancer has spread it becomes more difficult to treat successfully.

“It’s fascinating to discover how a simple bacteria could hold the key to powerful new approaches to treat breast cancer developing and spreading.”

More information: The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Hegde et al. Nature Chemistry.

Provided by Cancer Research UK

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Team finds mechanism linking key inflammatory marker to cancer

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.

Cancer created 4 hours ago | popularity not rated yet | comments 0 | with audio podcast

Study of young Israelis emphasizes need for avoidance of sun exposure for the very young

A new study conducted using extensive medical records of over one million Israeli adolescents before military service shows clearly how exposure to the Israeli sun of young, light-skinned children increases substantially ...

Cancer created 6 hours ago | popularity not rated yet | comments 0

Genetic diversity within tumors predicts outcome in head and neck cancer

A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue ...

Cancer created 10 hours ago | popularity not rated yet | comments 0

Molecular marker from pancreatic 'juices' helps identify pancreatic cancer

Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis—two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic ...

Cancer created 10 hours ago | popularity not rated yet | comments 0

New smartphone application improves colonoscopy preparation

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...

Cancer created May 19, 2013 | popularity not rated yet | comments 0


Researchers find far-reaching, microvascular damage in uninjured side of brain after stroke

While the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a ...

Breakup of physician, drug company relationship could improve health care, cut cost

A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...

One in ten teens using 'study drugs,' but parents aren't paying attention

As high schoolers prepare for final exams, teens nationwide may be tempted to use a "study drug"—a prescription stimulant or amphetamine—to gain an academic edge. But a new University of Michigan poll shows only one in ...

Food laboratory accuracy remains a concern

Food microbiology laboratories continue to submit false negative results and false positive results on a routine basis. A retrospective study of nearly 40,000 proficiency test results over the past 14 years, presented today ...

Study supports 'aggressive' treatment for posterior fossa hematoma in newborns

Posterior fossa subdural hematoma (PFSDH) is a serious and rare condition in newborns, generally occurring after difficult deliveries. But with appropriate treatment, there's an excellent chance of good long-term outcomes ...

Which women should be screened for high cholesterol?

National guidelines recommend that at-risk women be screened for elevated cholesterol levels to reduce their chances of developing cardiovascular disease. But who is 'at risk?' The results of a study by investigators ...